We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

Comorbidities Frequent in Cases of Fatal Anaphylaxis

By HospiMedica staff writers
Posted on 23 Apr 2007
A new study reports that the time between exposure and onset of severe symptoms in cases of fatal anaphylaxis is usually less than 30 minutes, and that comorbidities are frequent in such cases. More...


Researchers at the Northwestern University Feinberg School of Medicine (Chicago, IL, USA) conducted a retrospective case review and examined the causes of death, anatomical findings, and comorbid diseases in 25 episodes of fatal anaphylaxis. Each case report included details on the fatal reaction, a medical record review, and findings from laboratory and autopsy reports. Serum tryptase levels were measured in seven cases. Of the 25 cases of anaphylactic deaths, seven were reactions to medications; six were from radiocontrast media, six from Hymenoptera stings, and four from food. The remaining two cases possibly resulted from reactions to insect repellent and hair coloring products.

The anaphylactic reaction began within 30 minutes of allergen exposure in 21 cases. Thirteen of the cases died within 60 minutes. Four patients died between 1 and 6 hours after exposure, and four died between 24 and 96 hours after exposure. The time was unknown in four patients. Autopsies were performed in 23 cases. Of these, specific anatomical findings consistent with anaphylaxis were present in 18 cases. Of the seven patients in whom serum total tryptase was analyzed, four had markedly elevated levels. Overall, 22 patients (88%) had at least one comorbid condition identified pathologically at the time of death. The study was published in the March 2007 issue of the Annals of Allergy, Asthma, and Immunology.

"Patients who have experienced and survived an episode [of anaphylaxis] should try to identify the cause so that preventive measures...can be carried out,” said lead author Dr. Paul A. Greenberger. "Patients should be taught how and when to self-administer epinephrine if another episode of anaphylaxis begins.”


Related Links:
Northwestern University Feinberg School of Medicine

New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Medical Adhesive
MED 5570U
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.